ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SPI Spire Healthcare Group Plc

252.00
2.50 (1.00%)
30 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 1.00% 252.00 252.00 253.00 255.50 249.00 250.00 1,710,008 16:35:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 1.36B 27.3M 0.0676 37.43 1.02B

Spire Healthcare Group PLC Director/PDMR Shareholding

15/03/2024 10:07am

RNS Regulatory News


RNS Number : 0561H
Spire Healthcare Group PLC
15 March 2024
 

Spire Healthcare Group plc

15 March 2024

 

Notification of Transactions of Persons Discharging Managerial Responsibilities

This notification is made in accordance with DTR 3.1.4R (1) (a) of the Disclosure and Transparency Rules.

 

Grant of Deferred Share Bonus Plan (DSBP) Awards

Spire Healthcare Group plc (the Company) announces that on 14 March 2024, awards (the DSBP Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Company's DSBP.

 

Under the DSBP, Executive Directors are required to defer a proportion of their gross bonus, received in respect of the financial year ended 31 December 2023, into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DSBP:

 

Director

Percentage deferral of 2023 gross bonus*

Deferred Shares

Justin Ash

50%

152,786

Jitesh Sodha

33%

68,533

* To be disclosed in the 2023 Annual Report and Accounts

The share price used to determine the number of Deferred Shares subject to award was 238.0 pence, being the mid-market closing share price on 13 March 2024 (the dealing day prior to the awards being made).

The DSBP Awards will vest on the third anniversary of the grant date on 14 March 2027. 

Grant of Long Term Incentive Plan (LTIP) awards

The Company further announces that, on 14 March 2024, a performance share award was granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors and PDMR in the Company, under the rules of the Company's Long Term Incentive Plan.

 

Executive Director                Maximum number of shares under Award

Justin Ash                               542,575

 

Other PDMRs

John Forrest                            226,793

 

The number of shares set out above represents 200% of Justin Ash's base salary and 125% of John Forrest's base salary.  It is the maximum number which may vest under the LTIP Awards following the end of the performance period (31 December 2026).  The shareholder-approved Remuneration Policy permits awards of up to 200% of base salary for Executive Directors.

 

The actual number of shares which vest will depend on the extent to which the relevant performance conditions have been satisfied.

 

The performance conditions applicable to the LTIP Awards will be based as follows:

·    20% on relative total shareholder return (TSR) performance;

·    35% on ROCE performance;

·    15% on EBITDA Margin performance; and

·    30% on two Operational Excellence measures.

 

Further details of these performance conditions will be disclosed in the 2023 Annual Report and Accounts when published.

 

The share price used to determine the number of shares under the LTIP Awards was 237.0 pence being the average of the mid-market closing share price over the five trading days ending on 13 March 2024.

 

The transaction place is London.

 

Notes:

 

1)   For Justin Ash the 2024 LTIP awards described above will also be subject to a further two-year holding period following the vesting date.

2)   The actual number of shares which vest under the LTIP awards will depend on the extent to which the relevant performance conditions are satisfied in due course.

Name of contact and telephone number for queries:

Philip Davies

Company Secretary

Spire Healthcare Group plc

Tel:      07803 508348

 

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer/PDMR

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Grant of performance share awards under the Company's Deferred Share Bonus Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

152,786

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-14

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Jitesh Sodha

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer/PDMR

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Grant of performance share awards under the Company's Deferred Share Bonus Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

68,533

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-14

f)

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer/PDMR

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Grant of performance share awards under the Company's Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

542,575

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-14

f)

Place of the transaction

XLON

 

a)

Name

 

John Forrest

2

Reason for the notification

a)

Position/status

 

Chief Operating Officer/PDMR

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Grant of performance share awards under the Company's Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

226,793

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-03-14

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDXUGBDGSU

1 Year Spire Healthcare Chart

1 Year Spire Healthcare Chart

1 Month Spire Healthcare Chart

1 Month Spire Healthcare Chart

Your Recent History

Delayed Upgrade Clock